Evidence map›Paper›PMID 37712884›Full record

ArticleJournal of the American Chemical Society2023

Native Semisynthesis of Isopeptide-Linked Substrates for Specificity Analysis of Deubiquitinases and Ubl Proteases.

Zhou Zhao, Rachel O'Dea, Kim Wendrich, Nafizul Kazi, Malte Gersch

Open access · hybridAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Triboelectric Spectroscopy for In Situ Chemical Analysis of Liquids.Journal of the American Chemical Society · 2024
    Article
  12. Article
  13. Review
  14. USP16 is an ISG15 cross-reactive deubiquitinase that targets pro-ISG15 and ISGylated proteins involved in metabolism.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Zhou ZhaoChemical Genomics Centre, Max Planck Institute of Molecular Physiology, Otto-Hahn-Str. 15, 44227 Dortmund, Germany.ORCID 0000-0001-9350-7238
Rachel O'DeaChemical Genomics Centre, Max Planck Institute of Molecular Physiology, Otto-Hahn-Str. 15, 44227 Dortmund, Germany.
Kim WendrichChemical Genomics Centre, Max Planck Institute of Molecular Physiology, Otto-Hahn-Str. 15, 44227 Dortmund, Germany.ORCID 0000-0002-8305-2847
Nafizul KaziChemical Genomics Centre, Max Planck Institute of Molecular Physiology, Otto-Hahn-Str. 15, 44227 Dortmund, Germany.
Malte GerschChemical Genomics Centre, Max Planck Institute of Molecular Physiology, Otto-Hahn-Str. 15, 44227 Dortmund, Germany.ORCID 0000-0003-2767-9589
TU Dortmund University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Post-translational modifications with ubiquitin (Ub) and ubiquitin-like proteins (Ubls) are regulated by isopeptidases termed deubiquitinases (DUBs) and Ubl proteases. Here, we describe a mild chemical method for the preparation of fluorescence polarization substrates for these enzymes that is based on the activation of C-terminal Ub/Ubl hydrazides to acyl azides and their subsequent functionalization to isopeptides. The procedure is complemented by native purification routes and thus circumvents the previous need for desulfurization and refolding. Its broad applicability was demonstrated by the generation of fully cleavable substrates for Ub, SUMO1, SUMO2, NEDD8, ISG15, and Fubi. We employed these reagents for the investigation of substrate specificities of human UCHL3, USPL1, USP2, USP7, USP16, USP18, and USP36. Pronounced selectivity of USPL1 for SUMO2/3 over SUMO1 was observed, which we rationalize with crystal structures and biochemical assays, revealing a SUMO paralogue specificity mechanism distinct from SENP family deSUMOylases. Moreover, we investigated the recently identified Fubi proteases USP16 and USP36 and found both to act as bona fide deFubiylases, harboring catalytic activity against isopeptide-linked Fubi. Surprisingly, we also noticed the activity of both enzymes toward ISG15, previously not identified in chemoproteomics, which makes USP16 and USP36 the first human DUBs with specific isopeptidase activity toward three distinct modifiers. The methods described here for the preparation of isopeptide-linked, fully folded substrates will aid in the characterization of further DUBs/Ubl proteases. More broadly, our findings highlight possible limitations associated with fluorogenic substrates and Ubl activity-based probes and stress the importance of isopeptide-containing reagents for validating isopeptidase activities and quantifying substrate specificities.

Indexed as

EndopeptidasesPeptide HydrolasesAzidesDeubiquitinating EnzymesHumansUbiquitinUbiquitin-Specific Peptidase 7Ubiquitin ThiolesteraseAzidesDeubiquitinating EnzymesEndopeptidasesPeptide HydrolasesUbiquitinUbiquitin-Specific Peptidase 7Ubiquitin ThiolesteraseUCHL3 protein, humanUSP18 protein, humanUSP36 protein, humanUSP7 protein, human

Identifiers

PMID37712884
PMCPMC10540217
OpenAlexW4386758110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.